aminopterin
aminopterin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
Aminopterin · mesh:M0000962
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- aminopterinRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
Aminopterin in Treating Patients With Refractory Leukemia
Clinical Trials (4)
Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
Aminopterin in Treating Patients With Refractory Leukemia
All 4 trials loaded
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 4